The growing prevalence of chronic kidney disease and cardiac arrhythmias is expected to be among major factors driving the growth of the hyperkalaemia treatment market over the forecast period. According to Centres for Disease Control and Prevention (CDC) 15% or 30 million people suffer from chronic kidney diseases.
Growing Prevalence of Chronic Kidney Disease Propels The Demand for Hyperkalaemia Treatment Says Fac pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.